These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 17612393)
1. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells. Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447 [TBL] [Abstract][Full Text] [Related]
3. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. Dandekar DS; Lopez M; Carey RI; Lokeshwar BL Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368 [TBL] [Abstract][Full Text] [Related]
5. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related]
6. Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade. Cao J; Yang X; Li WT; Zhao CL; Lv SJ Asian Pac J Cancer Prev; 2014; 15(22):9967-72. PubMed ID: 25520137 [TBL] [Abstract][Full Text] [Related]
7. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway. Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869 [TBL] [Abstract][Full Text] [Related]
8. [Celecoxib increased cellular ATRA sensitivity of human colon cancer cell lines through COX-2-independent mechanisms]. Liu JP; Wei HB; Zheng ZH; Guo WP; Fang JF Yao Xue Xue Bao; 2009 Dec; 44(12):1353-8. PubMed ID: 21351468 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines. Singh B; Irving LR; Tai K; Lucci A J Surg Res; 2010 Oct; 163(2):235-43. PubMed ID: 20691996 [TBL] [Abstract][Full Text] [Related]
11. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675 [TBL] [Abstract][Full Text] [Related]
12. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Gallouet AS; Travert M; Bresson-Bepoldin L; Guilloton F; Pangault C; Caulet-Maugendre S; Lamy T; Tarte K; Guillaudeux T Clin Cancer Res; 2014 May; 20(10):2663-73. PubMed ID: 24637636 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines. Meric F; Liao Y; Lee WP; Pollock RE; Hung MC Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226 [TBL] [Abstract][Full Text] [Related]
14. [Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway]. Wang L; Liu LH; Shan BE; Zhang C; Sang MX; Li J Ai Zheng; 2009 Jun; 28(6):569-74. PubMed ID: 19635192 [TBL] [Abstract][Full Text] [Related]
15. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894 [TBL] [Abstract][Full Text] [Related]
16. Involvement of Bcl-X(L) deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells. Chang CY; Lin YM; Lee WP; Hsu HH; Chen EI Oncogene; 2006 Apr; 25(18):2656-65. PubMed ID: 16331250 [TBL] [Abstract][Full Text] [Related]
17. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis. Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]